Changes in Medical Services and Drug Utilization and Associated Costs After Narcolepsy Diagnosis in the United States

摘要

BackgroundHealthcare utilization and the cost implications associated with undiagnosed and/or misdiagnosed narcolepsy have not been evaluated, and there is scant literature characterizing the newly diagnosed population with narcolepsy with respect to treatment patterns and resource utilization.